(Q44014994)
Statements
1 reference
A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment (English)
1 reference
Naomi N Bock
1 reference
Timothy R Sterling
1 reference
Carol D Hamilton
1 reference
Connie Pachucki
1 reference
Yong-Cheng Wang
1 reference
Donna S Conwell
1 reference
Ann Mosher
1 reference
Mary Samuels
1 reference
Andrew Vernon
1 reference
Tuberculosis Trials Consortium, Centers for Disease Control and Prevention, Atlanta, Georgia
1 reference
1 June 2002
1 reference
1 reference
165
1 reference
11
1 reference
1526-1530
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference